All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CLYM / Climb Bio, Inc.
|
|
|
|
|
|
|
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
HUMA / Humacyte, Inc.
|
|
|
|
|
|
|
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MNPR / Monopar Therapeutics Inc.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
SPRY / ARS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
ZURA / Zura Bio Limited
|
|
|
|
|
|
|
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
PCSC / Perceptive Capital Solutions Corp
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
PEPG / PepGen Inc.
|
|
|
|
|
|
|
|
HOWL / Werewolf Therapeutics, Inc.
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
THRD / Third Harmonic Bio, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
DRUG / Bright Minds Biosciences Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
RXST / RxSight, Inc.
|
|
|
|
|
|
|
|
CBLL / CeriBell, Inc.
|
|
|
|
|
|
|
|
APGE / Apogee Therapeutics, Inc.
|
|
|
|
|
|
|
|
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
|
|
|
|
|
|
|
|
RXRX / Recursion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
SCILEX HOLDING CO
/ SH (80880W106) |
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
GKOS / Glaukos Corporation
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
MBX / MBX Biosciences, Inc.
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
BCAX / Bicara Therapeutics Inc.
|
|
|
|
|
|
|
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
LXEO / Lexeo Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
GHRS / GH Research PLC
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
ARTV / Artiva Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
SEPN / Septerna, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACRV / Acrivon Therapeutics, Inc.
|
|
|
|
|
|
|
|
VOR / Vor Biopharma Inc.
|
|
|
|
|
|
|
|
ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
BBNX / Beta Bionics, Inc.
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
SERA / Sera Prognostics, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
BIOA / BioAge Labs, Inc.
|
|
|
|
|
|
|
|
SION / Sionna Therapeutics, Inc.
|
|
|
|
|
|
|
|
MTSR / Metsera, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|